Immatics NV (IMTX) financial statements

Healthcare · Biotechnology · Market cap $1.1B

Net income was -196M EUR.

Free cash flow was -183M EUR.

The diluted share count rose 270% over the period (dilution).

Income statement

Fiscal years, in EUR, from Immatics NV's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Research and development34M EUR40M EUR67M EUR88M EUR107M EUR119M EUR148M EUR184M EUR
Selling, general and admin8M EUR12M EUR34M EUR34M EUR36M EUR38M EUR46M EUR51M EUR
Operating income-34M EUR-33M EUR-70M EUR-86M EUR30M EUR-102M EUR-39M EUR-182M EUR
Interest expense161,000 EUR264,000 EUR289,000 EUR566,000 EUR1M EUR831,000 EUR886,000 EUR946,000 EUR
Pre-tax income-32M EUR-32M EUR-212M EUR-93M EUR42M EUR-97M EUR21M EUR-198M EUR
Income tax0 EUR0 EUR0 EUR0 EUR14M EUR-2M EUR6M EUR-2M EUR
Net income-31M EUR-32M EUR-211M EUR-93M EUR28M EUR-95M EUR15M EUR-196M EUR
EPS (diluted)——-4.40 EUR-1.48 EUR0.40 EUR-1.18 EUR0.14 EUR-1.61 EUR
Diluted shares33M33M48M63M69M81M107M122M

Balance sheet

Fiscal years, in EUR, from Immatics NV's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Cash and short-term investments39M EUR103M EUR208M EUR133M EUR149M EUR218M EUR237M EUR346M EUR
Receivables—957,000 EUR1M EUR682,000 EUR1M EUR4M EUR6M EUR6M EUR
Total current assets—124M EUR239M EUR152M EUR377M EUR449M EUR630M EUR504M EUR
Property, plant and equipment—5M EUR8M EUR11M EUR13M EUR44M EUR50M EUR42M EUR
Total assets—134M EUR255M EUR175M EUR408M EUR510M EUR696M EUR562M EUR
Total current liabilities—69M EUR77M EUR95M EUR106M EUR157M EUR68M EUR43M EUR
Total liabilities—175M EUR167M EUR151M EUR204M EUR292M EUR121M EUR78M EUR
Shareholders' equity-9M EUR-42M EUR87M EUR24M EUR203M EUR218M EUR575M EUR484M EUR
Net debt-39M EUR-103M EUR-208M EUR-133M EUR-149M EUR-218M EUR-237M EUR-346M EUR

Cash flow

Fiscal years, in EUR, from Immatics NV's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Operating cash flow21M EUR71M EUR-81M EUR-85M EUR100M EUR18M EUR-158M EUR-177M EUR
Capital spending507,000 EUR2M EUR8M EUR6M EUR6M EUR31M EUR16M EUR7M EUR
Free cash flow20M EUR69M EUR-88M EUR-90M EUR94M EUR-13M EUR-175M EUR-183M EUR
Stock-based compensation1M EUR700,000 EUR45,000 EUR—————
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for IMTX.
Open IMTX in Investingly

Questions

How much free cash flow does Immatics NV generate?

-183M EUR in fiscal 2025 (operating cash flow minus capital spending).

From Immatics NV's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.